Arcutis Biotherapeutics, Inc. (ARQT)

29.04 +0.96 (+3.42%) USD  |  NASDAQ  |  Dec 31, 16:00
29.27 +0.23 (+0.79%) Pre-Market: 08:23
More

Arcutis Biotherapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
CorMedix, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Editas Medicine, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade